Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 1
2015 1
2016 1
2018 1
2019 13
2020 10
2021 7
2022 14
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
An update on VEXAS syndrome.
Al-Hakim A, Savic S. Al-Hakim A, et al. Expert Rev Clin Immunol. 2023 Feb;19(2):203-215. doi: 10.1080/1744666X.2023.2157262. Epub 2022 Dec 26. Expert Rev Clin Immunol. 2023. PMID: 36537591 Free article. Review.
A detailed account of its various clinical manifestations and disease mimics is provided. Current treatment and management options are discussed. EXPERT OPINION: New rare variants in UBA1 and VEXAS-like UBA1 negative cases are reported. ...
A detailed account of its various clinical manifestations and disease mimics is provided. Current treatment and management options ar …
The IL-4, IL-13 and IL-31 pathways in atopic dermatitis.
Dubin C, Del Duca E, Guttman-Yassky E. Dubin C, et al. Expert Rev Clin Immunol. 2021 Aug;17(8):835-852. doi: 10.1080/1744666X.2021.1940962. Epub 2021 Jul 21. Expert Rev Clin Immunol. 2021. PMID: 34106037 Review.
We will also detail novel targeted therapeutics that have recently been or are currently in clinical trials for AD. A literature search was conducted by querying Scopus, Google Scholar, PubMed, and Clinicaltrials.gov up to January 2021 using combinations of the search term …
We will also detail novel targeted therapeutics that have recently been or are currently in clinical trials for AD. A literature sear …
Comorbid allergic rhinitis and asthma: important clinical considerations.
Nappi E, Paoletti G, Malvezzi L, Ferri S, Racca F, Messina MR, Puggioni F, Heffler E, Canonica GW. Nappi E, et al. Expert Rev Clin Immunol. 2022 Jul;18(7):747-758. doi: 10.1080/1744666X.2022.2089654. Epub 2022 Jun 19. Expert Rev Clin Immunol. 2022. PMID: 35695326 Review.
EXPERT OPINION: We believe that there are several unmet needs for our patients, however, there are promising advances forecasted for the future. ...A multidisciplinary approach should characterize the journey of patients with respiratory allergies, with an adequate …
EXPERT OPINION: We believe that there are several unmet needs for our patients, however, there are promising advances forecasted for …
Adherence to medication in children and adolescents with asthma: methods for monitoring and intervention.
Pearce CJ, Fleming L. Pearce CJ, et al. Expert Rev Clin Immunol. 2018 Dec;14(12):1055-1063. doi: 10.1080/1744666X.2018.1532290. Epub 2018 Oct 15. Expert Rev Clin Immunol. 2018. PMID: 30286679 Free article. Review.
Areas covered: Several measurement tools have been developed to assess adherence in adults and children with asthma. The current methods for measuring adherence, both subjective and objective, have several flaws and even the current gold standard, electronic monitor …
Areas covered: Several measurement tools have been developed to assess adherence in adults and children with asthma. The current meth …
Allergen immunotherapy: progress and future outlook.
Šošić L, Paolucci M, Flory S, Jebbawi F, Kündig TM, Johansen P. Šošić L, et al. Expert Rev Clin Immunol. 2023 Jul-Dec;19(7):745-769. doi: 10.1080/1744666X.2023.2209319. Epub 2023 May 5. Expert Rev Clin Immunol. 2023. PMID: 37122076 Review.
INTRODUCTION: Allergy, the immunological hypersensitivity to innocuous environmental compounds, is a global health problem. ...AREAS COVERED: This review will aim to give an overview of the state-of-the-art allergy management, including the use of new biologi …
INTRODUCTION: Allergy, the immunological hypersensitivity to innocuous environmental compounds, is a global health problem. .. …
The clinical implications of the microbiome in the development of allergy diseases.
Koidl L, Untersmayr E. Koidl L, et al. Expert Rev Clin Immunol. 2021 Feb;17(2):115-126. doi: 10.1080/1744666X.2021.1874353. Epub 2021 Jan 19. Expert Rev Clin Immunol. 2021. PMID: 33428498 Review.
Introduction: A substantial number of patients worldwide are affected by allergies. Emerging evidence suggests that the individual microbial composition might contribute to the development of allergies or might even protect from allergic diseases.Areas covered: This …
Introduction: A substantial number of patients worldwide are affected by allergies. Emerging evidence suggests that the individual mi …
Establishing diagnostic strategies for cannabis allergy.
Toscano A, Elst J, van der Poorten ML, Beyens M, Heremans K, Decuyper II, Van Gasse AL, Mertens C, Van Houdt M, Hagendorens MM, Sabato V, Ebo DG. Toscano A, et al. Expert Rev Clin Immunol. 2022 Oct;18(10):1015-1022. doi: 10.1080/1744666X.2022.2108791. Epub 2022 Aug 2. Expert Rev Clin Immunol. 2022. PMID: 35912836 Review.
EXPERT OPINION: At present, the diagnosis of IgE-mediated cannabis allergy is based on a three-step approach that starts with accurate history taking and ends with a confirmation of sensitization to the whole extract and, finally, molecular components. Although much …
EXPERT OPINION: At present, the diagnosis of IgE-mediated cannabis allergy is based on a three-step approach that starts with …
Olfactory dysfunction in chronic rhinosinusitis: insights into the underlying mechanisms and treatments.
Song J, Wang M, Wang C, Zhang L. Song J, et al. Expert Rev Clin Immunol. 2023 Jul-Dec;19(8):993-1004. doi: 10.1080/1744666X.2023.2235891. Epub 2023 Jul 13. Expert Rev Clin Immunol. 2023. PMID: 37432663 Review.
Additionally, the methods used for detection of olfaction and both currently available and potentially new clinical treatments for OD are reviewed. ...The current treatment for OD in CRS is mainly aimed at attenuating and preventing inflammation. ...
Additionally, the methods used for detection of olfaction and both currently available and potentially new clinical treatments for OD …
Basophil activation test in the food allergy clinic: its current use and future applications.
Bergmann MM, Santos AF. Bergmann MM, et al. Expert Rev Clin Immunol. 2024 Apr 10:1-8. doi: 10.1080/1744666X.2024.2336568. Online ahead of print. Expert Rev Clin Immunol. 2024. PMID: 38591129 Review.
AREAS COVERED: In this review, we summarize the evidence to support clinical use of BAT and the next steps required for clinical implementation for an improve clinical care for patients with suspected IgE-mediated food allergy. EXPERT OPINION: BAT has recently been …
AREAS COVERED: In this review, we summarize the evidence to support clinical use of BAT and the next steps required for clinical implementat …
Peanut allergy: risk factors, immune mechanisms, and best practices for oral immunotherapy success.
Tirumalasetty J, Barshow S, Kost L, Morales L, Sharma R, Lazarte C, Nadeau KC. Tirumalasetty J, et al. Expert Rev Clin Immunol. 2023 Jul-Dec;19(7):785-795. doi: 10.1080/1744666X.2023.2209318. Epub 2023 May 5. Expert Rev Clin Immunol. 2023. PMID: 37129440 Review.
AREAS COVERED: In this review, we describe the natural history of peanut allergy, summarize immunological and clinical outcomes of pOIT at different ages, discuss the optimization of pOIT in key age groups, and finally suggest an ideal age range at which to initiate pOIT f …
AREAS COVERED: In this review, we describe the natural history of peanut allergy, summarize immunological and clinical outcomes of pO …
56 results